Cite
Intravenous glutamine appears to reduce the severity of symptomatic platinum-induced neuropathy: a prospective randomized study
MLA
Wen-Hsiang Chen, et al. “Intravenous Glutamine Appears to Reduce the Severity of Symptomatic Platinum-Induced Neuropathy: A Prospective Randomized Study.” Journal of Chemotherapy (Florence, Italy), vol. 27, no. 4, Mar. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34cd50487694d4ae70c85c59fb318966&authtype=sso&custid=ns315887.
APA
Wen-Hsiang Chen, Pei-Hung Chang, Jen-Seng Huang, Chia-Lung Wu, Chung-Wei Fan, & Kun-Yun Yeh. (2015). Intravenous glutamine appears to reduce the severity of symptomatic platinum-induced neuropathy: a prospective randomized study. Journal of Chemotherapy (Florence, Italy), 27(4).
Chicago
Wen-Hsiang Chen, Pei-Hung Chang, Jen-Seng Huang, Chia-Lung Wu, Chung-Wei Fan, and Kun-Yun Yeh. 2015. “Intravenous Glutamine Appears to Reduce the Severity of Symptomatic Platinum-Induced Neuropathy: A Prospective Randomized Study.” Journal of Chemotherapy (Florence, Italy) 27 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34cd50487694d4ae70c85c59fb318966&authtype=sso&custid=ns315887.